Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC – Get Free Report) shares shot up 0.6% during mid-day trading on Wednesday . The stock traded as high as $27.24 and last traded at $27.18. 723 shares were traded during mid-day trading, a decline of 79% from the average session volume of 3,364 shares. The stock had previously closed at $27.03.
Virtus LifeSci Biotech Clinical Trials ETF Trading Up 0.6 %
The stock has a fifty day moving average of $27.24 and a 200-day moving average of $27.45.
Virtus LifeSci Biotech Clinical Trials ETF Company Profile
The Virtus LifeSci Biotech Clinical Trials ETF (BBC) is an exchange-traded fund that mostly invests in health care equity. The fund tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials. BBC was launched on Dec 16, 2014 and is managed by Virtus.
Featured Stories
- Five stocks we like better than Virtus LifeSci Biotech Clinical Trials ETF
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Why Dick’s Could Be a Slam Dunk for Your Investment Portfolio
- How to Calculate Options Profits
- Introduction to Fibonacci Retracement Levels
- The Risks of Owning Bonds
- Top 3 Stocks to Outperform the S&P 500 in a Downturn
Receive News & Ratings for Virtus LifeSci Biotech Clinical Trials ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Virtus LifeSci Biotech Clinical Trials ETF and related companies with MarketBeat.com's FREE daily email newsletter.
